Phenolsulphonic Acid

Phenolsulphonic Acid

SCHEMBL156887

N.O=S(=O)(O)c1ccccc1O

nearest known ligand 0.44

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ AURKA O14965 1/20 0.44
▸ AURKB Q96GD4 1/20 0.44
▸ SMN1; SMN2 Q16637 2/20 0.44
▸ TSHR P16473 1/20 0.44
▸ MYC P01106 1/20 0.44
▸ CDK2 P24941 1/20 0.43
▸ CA2 P00918 3/20 0.43
▸ CA4 P22748 3/20 0.43
▸ LMNA P02545 2/20 0.43
▸ HPGD P15428 2/20 0.43
▸ HIF1A Q16665 2/20 0.43
▸ HSD17B10 Q99714 2/20 0.43
▸ POLB P06746 2/20 0.43
▸ CA12 O43570 2/20 0.43
▸ CA5A P35218 2/20 0.43
▸ CA14 Q9ULX7 2/20 0.43
▸ CA5B Q9Y2D0 2/20 0.43
▸ KDM4E B2RXH2 1/20 0.43
▸ NPC1 O15118 1/20 0.43
▸ GMNN O75496 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Phenolsulphonic Acid SCHEMBL29449532 0.97 SMN1; SMN2 (0.46) AURKAAURKBSMN1; SMN2TSHRMYC
Phenolsulphonic Acid SCHEMBL18274 0.97 SMN1; SMN2 (0.46) AURKAAURKBSMN1; SMN2TSHRMYC
Phenolsulphonic Acid SCHEMBL11154671 0.97 SMN1; SMN2 (0.46) AURKAAURKBSMN1; SMN2TSHRMYC
Phenolsulphonic Acid SCHEMBL9491240 0.95 AURKA (0.44) AURKAAURKBSMN1; SMN2TSHRMYC
Phenolsulphonic Acid SCHEMBL20815894 0.95 AURKA (0.44) AURKAAURKBSMN1; SMN2TSHRMYC
Phenolsulphonic Acid SCHEMBL4130732 0.95 AURKA (0.44) AURKAAURKBSMN1; SMN2TSHRMYC
Phenolsulphonic Acid SCHEMBL812225 0.95 AURKA (0.44) AURKAAURKBSMN1; SMN2TSHRMYC
Phenolsulphonic Acid SCHEMBL2519915 0.95 AURKA (0.44) AURKAAURKBSMN1; SMN2TSHRMYC
Phenolsulphonic Acid SCHEMBL2581592 0.95 AURKA (0.44) AURKAAURKBSMN1; SMN2TSHRMYC
Phenolsulphonic Acid SCHEMBL9169950 0.95 AURKA (0.44) AURKAAURKBSMN1; SMN2TSHRMYC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 565 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025235586-A1 DENTINAL HYPERSENSITIVITY TREATMENT EPIEN MEDICAL, INC. (US) 2025-11-13 — — WO claimed
US-20150342912-A1 METHOD AND FORMULATION FOR TREATING MUCOSAL DISCONTINUITIES AND FOR REDUCING BIOFILMS EPIEN MEDICAL, INC. 2015-12-03 — — US claimed
EP-1587477-B1 ODORLESS FORMULATION FOR TREATING MUCOSAL DISCONTINUITIES EPIEN MEDICAL INC (US) 2011-10-26 — — EP claimed
US-7514070-B2 Method for exfoliating skin EPIEN MEDICAL, INC. (US) 2009-04-07 — — US claimed
US-20070005026-A1 METHOD AND MATERIAL FOR REDUCING BIOFILM EPIEN MEDICAL, INC. 2007-01-04 — — US claimed
WO-2007002194-A2 METHOD AND MATERIAL FOR REDUCING BIOFILM EPIEN MEDICAL, INC. (US) 2007-01-04 — — WO claimed
US-7132111-B2 reacting guaiacol and phenol with sulfuric acid and water to make a preselected concentration of preselected isomers of phenolsulfonic acid and guaiacolsulfonic acid; treating periodontal disease and canker sores; exfoliants for feet and faces. EPIEN MEDICAL, INC. (US) 2006-11-07 — — US claimed
EP-1587477-A2 ODORLESS FORMULATION FOR TREATING MUCOSAL DISCONTINUITIES Epien Medical, Inc. (US) 2005-10-26 — — EP claimed
WO-2004062580-A2 ODORLESS FORMULATION FOR TREATING MUCOSAL DISCONTINUITIES EPIEN MEDICAL, INC (US) 2004-07-29 — — WO claimed
US-20040132810-A1 Odorless formulation for treating mucosal discontinuities EPIEN MEDICAL, INC. 2004-07-08 — — US claimed
US-6171581-B1 0.1-30% OF A SILICONE ELASTOMER, 0.05-30% OF A GELLANT, 1-25% OF AN ANTIPERSPIRANT OR DEODORANT ACTIVE, 1-90% WATER, AND 1-75% OIL. REVLON CONSUMER PRODUCTS CORPORATION 2001-01-09 — — US claimed
EP-0153223-B1 PROCESS FOR THE PREPARATION OF PARA-ACYLOXYBENZENE SULFONATES BY BASIC CATALYSIS RHONE-POULENC CHIMIE (FR) 1986-12-17 — — EP claimed
EP-0153222-B1 PROCESS FOR THE PREPARATION OF PARA-ACYLOXYBENZEN SULFONATES BY ACID CATALYSIS RHONE-POULENC CHIMIE (FR) 1986-12-17 — — EP claimed
US-4511631-A Metallic chromium-nickel-hydrated chromium oxide-coated tin free steel and process for the production thereof TOYO KOHAN CO., LTD. (JP) 1985-04-16 — — US claimed
US-4508790-A MULTILAYER-CHROMIUM, NICKEL-ZINC ALLOY, AND HYDRATED CHROMIUM OXID TOYO KOHAN CO., LTD. (JP) 1985-04-02 — — US claimed
EP-4727510-A2 WOUND CARE AND METHOD FOR PREVENTING WOUND INFECTION Epien Medical Inc. (US) 2026-04-22 — — EP disclosed
EP-4413055-B1 STABILIZED RHEOLOGY MODIFIER EMULSIONS LUBRIZOL ADVANCED MAT INC (US) 2025-12-03 — — EP disclosed
US-4508790-A MULTILAYER-CHROMIUM, NICKEL-ZINC ALLOY, AND HYDRATED CHROMIUM OXID TOYO KOHAN CO., LTD. (JP) 1985-04-02 — — US disclosed
US-4383098-A HIGH SPEED CURING OF POLYMER USING A METAL SULFONATE ACID CATALYSTS; POT LIFE; FOUNDRIES THE QUAKER OATS COMPANY (US) 1983-05-10 — — US disclosed
US-4317763-A CURABLE RESIN BINDER AND A SALT OF A LOWER ALIPHATIC OR AROMATIC SULFONIC ACID THE QUAKER OATS COMPANY (US) 1982-03-02 — — US disclosed
Send feedback